SCHEMBL39133

SCHEMBL39133

[O]CC(F)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11659736 0.68
SCHEMBL4953700 0.68
SCHEMBL179883 0.67
SCHEMBL15264169 0.67
SCHEMBL3679210 0.65
SCHEMBL3759334 0.64
SCHEMBL17390952 0.64
SCHEMBL14720843 0.64
SCHEMBL11824482 0.64
SCHEMBL2382240 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12036319-B2 Polyvalent sting activating compositions and uses thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-16 US disclosed
WO-2024112397-A1 COMBINATION THERAPIES COMPRISING KRAS INHIBITORS AND SPH2 INHIBITORS HUYABIO INTERNATIONAL, LLC (US) 2024-05-30 WO disclosed
US-20240141084-A1 BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME SILQ TECHNOLOGIES CORPORATION 2024-05-02 US disclosed
US-11970731-B2 Enhancement of nucleic acid polymerization by aromatic compounds Roche Sequencing Solutions, Inc. (US) 2024-04-30 US disclosed
US-11964971-B2 Methods and compositions for modulating splicing SKYHAWK THERAPEUTICS, INC. (US) 2024-04-23 US disclosed
EP-4333850-A1 SHP2 INHIBITOR MONOTHERAPY AND USES THEREOF Huyabio International, LLC (US) 2024-03-13 EP disclosed
EP-4334318-A1 COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND PD-1 INHIBITORS Huyabio International, LLC (US) 2024-03-13 EP disclosed
EP-4334317-A1 COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND EGFR TYROSINE KINASE INHIBITORS Huyabio International, LLC (US) 2024-03-13 EP disclosed
CN-117677619-A Combination therapy comprising an SHP2 inhibitor and a PD-1 inhibitor 沪亚生物国际有限责任公司 2024-03-08 CN disclosed
EP-3568390-B1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) 2024-03-06 EP disclosed
US-5753635-A Purine derivatives and their use as anti-coagulants BERLEX LABORATORIES, INC. (US) 1998-05-19 US disclosed
WO-1998015547-A1 THIO ACID DERIVED MONOCYCLIC N-HETEROCYCLICS AS ANTICOAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-04-16 WO disclosed
WO-1998011094-A1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY CYCLIC AMINO ACID OR CYCL IC HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-03-19 WO disclosed
WO-1998007723-A1 BICYCLIC PYRIMIDINE DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-02-26 WO disclosed
WO-1998007725-A1 PURINE DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-02-26 WO disclosed
EP-0813525-A1 BENZAMIDINE DERIVATIVES THEIR PREPARATION AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 1997-12-29 EP disclosed
US-5693641-A ENZYME INHIBITOR TREATING BLOOD DISORDER BERLEX LABORATORIES INC. (US) 1997-12-02 US disclosed
US-5691364-A Benzamidine derivatives and their use as anti-coagulants BERLEX LABORATORIES, INC. (US) 1997-11-25 US disclosed
WO-1997029067-A1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (DE) 1997-08-14 WO disclosed
WO-1996028427-A1 BENZAMIDINE DERIVATIVES THEIR PREPARATION AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 1996-09-19 WO disclosed